Read more about the requirements to our board of directors and how the board is comprised
Read more about the rules of procedure for our leadership team
Read more about the guidelines for compensation of the board of directors and executive leadership team
The annual shareholder’s meeting ensures the basic right of shareholders to receive information and participate in key decisions regarding Novozymes
Read more about the purpose of Novozymes and how we comply with the recommendations on corporate governance
Easy access to find our reporting on corporate governance in our latest annual report
Novozymes’ position on business integrity rests on six integrity principles to which all employees, including executives, officers and directors, must adhere. Read more about them here
Novozymes is committed to ensuring high standards in everything we do and to conducting our business operations in a responsible way
If you become aware of illegal or unethical misconduct, we strongly encourage you to report it to Novozymes either through your regular channels of communication or using Novozymes' Whistleblower Hotline
Corporate governance refers to the way a company is lead and controlled. Novozymes' values are consistent with the principles of good governance.
The Board of Directors and Executive Leadership Team of Novozymes believe that corporate governance initiatives should be a constant process and address the principles of good corporate governance in an ongoing process with due consideration to current legislation, practice and recommendations. Such evaluation includes a review of the company’s business concept, business procedures, goals, organization, capital position, stakeholder relations, risks and the exercise of control.
This section describes corporate governance at Novozymes in relation to shareholder meetings, the Board of Directors, and Executive Leadership Team, as well as includes the statutory report on corporate governance.
Once a year the Board of Directors considers the Danish Committee on Corporate Governance’s recommendations for good corporate governance.
As required for a listed company on Nasdaq OMX Nordic under the rules for issuers of shares Novozymes issues a statement of compliance with the Danish Committee on Corporate Governance's recommendations using the "comply or explain"-principle. Novozymes’ position on the individual recommendations is described here.
We encourage all shareholders and investment professionals to contact us, should you have any questions or requests concerning Novozymes.
Meet the whole team
Ofte stillede spørgsmål
Stay up to date with Investor email alerts.